ZYTO Corp. Announces Strategic Marketing Alliance with XYMOGEN Improves Revenue
ZYTO Corp. has announced that it has entered into a strategic marketing agreement with XYMOGEN for the sale of ZYTO technology to XYMOGEN customers. The joint marketing agreement brings higher sales revenues to both companies.
Orem, UT, July 28, 2007 --(PR.com)-- ZYTO Corp. (OTC - ZYTC.pk) has announced a strategic marketing alliance with XYMOGEN, Inc. of Orlando, FL for the sale of ZYTO (tm) technology to the healthcare practitioners who are customers of XYMOGEN.
The marketing arrangement is expected to bring increased revenues to both companies, according to Dr. Vaughn R. Cook, OMD, president and founder of Zyto Corp.
“The use of ZYTO technology by the healthcare practitioners who use XYMOGEN formulas for their patients and clients will bring higher sales to both companies. ZYTO will benefit from the sales of our technology, and XYMOGEN will benefit because healthcare practitioners will use ZYTO technology to help them determine what XYMOGEN formulas will be best for their clients and patients,” explained Cook.
XYMOGEN is a leading provider of research based, high-quality, nutraceuticals and functional foods exclusively to the licensed healthcare professional. XYMOGEN formulas are manufactured in a Federal Drug Registered, State Board of Pharmacy cGMP Manufacturing Facility and are available in vegetable based capsules, sublingual and control-released tablets, soft-gels or powders, according to Brian Blackburn, C.E.O. and XYMOGEN founder.
“ZYTO technology will enable our healthcare providers to do a better job of finding solutions for their patients using the products available through XYMOGEN. We believe that healthcare practitioners who use ZYTO technology provide the most reliable method of delivery for nutritional supplements,” said Blackburn.
ZYTO technology enables healthcare practitioners to communicate with the human body on a cellular level, according to Cook.
“Zyto technology converts computer data to signatures or frequencies that stimulate cellular response, known as virtual stressors or queries. The process of talking with the body can be seen as a stimulus-response exercise. Zyto technology outputs a query, or virtual stressor, and the body responds,” said Cook. “Healthcare practitioners use this information to determine the best way to help their patients or clients.”
ZYTO Corp. has a growing number of companies that have agreed to the marketing alliance because it benefits all parties. This arrangement has brought a rapid increase in sales for ZYTO and the companies that participate in the marketing alliance.
ZYTO Corp. has a web site at http://www.ZYTO.com and XYMOGEN has a web site at http://www.XYMOGEN.com
About ZYTO Corp.
ZYTO Corp. was founded by Dr. Vaughn Cook, OMD. The company provides computerized bio-technology equipment and software with clinical applications that include obtaining information from the human body to assist healthcare practitioners to make better decisions.
Forward Looking Statement:
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports the Company may file.
Press Contact:
David M. Bresnahan
801-224-7199
###
The marketing arrangement is expected to bring increased revenues to both companies, according to Dr. Vaughn R. Cook, OMD, president and founder of Zyto Corp.
“The use of ZYTO technology by the healthcare practitioners who use XYMOGEN formulas for their patients and clients will bring higher sales to both companies. ZYTO will benefit from the sales of our technology, and XYMOGEN will benefit because healthcare practitioners will use ZYTO technology to help them determine what XYMOGEN formulas will be best for their clients and patients,” explained Cook.
XYMOGEN is a leading provider of research based, high-quality, nutraceuticals and functional foods exclusively to the licensed healthcare professional. XYMOGEN formulas are manufactured in a Federal Drug Registered, State Board of Pharmacy cGMP Manufacturing Facility and are available in vegetable based capsules, sublingual and control-released tablets, soft-gels or powders, according to Brian Blackburn, C.E.O. and XYMOGEN founder.
“ZYTO technology will enable our healthcare providers to do a better job of finding solutions for their patients using the products available through XYMOGEN. We believe that healthcare practitioners who use ZYTO technology provide the most reliable method of delivery for nutritional supplements,” said Blackburn.
ZYTO technology enables healthcare practitioners to communicate with the human body on a cellular level, according to Cook.
“Zyto technology converts computer data to signatures or frequencies that stimulate cellular response, known as virtual stressors or queries. The process of talking with the body can be seen as a stimulus-response exercise. Zyto technology outputs a query, or virtual stressor, and the body responds,” said Cook. “Healthcare practitioners use this information to determine the best way to help their patients or clients.”
ZYTO Corp. has a growing number of companies that have agreed to the marketing alliance because it benefits all parties. This arrangement has brought a rapid increase in sales for ZYTO and the companies that participate in the marketing alliance.
ZYTO Corp. has a web site at http://www.ZYTO.com and XYMOGEN has a web site at http://www.XYMOGEN.com
About ZYTO Corp.
ZYTO Corp. was founded by Dr. Vaughn Cook, OMD. The company provides computerized bio-technology equipment and software with clinical applications that include obtaining information from the human body to assist healthcare practitioners to make better decisions.
Forward Looking Statement:
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition for the Company, new products and technological changes, the Company's dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports the Company may file.
Press Contact:
David M. Bresnahan
801-224-7199
###
Contact
Zyto Corp.
David M. Bresnahan
801-224-7199 ext. 227
www.zyto.com
David M. Bresnahan
801-224-7199 ext. 227
www.zyto.com
Contact
Categories